Low-grade fibromyxoid sarcoma: a clinicopathologic and molecular study of 10 genetically confirmed cases
- PMID: 31949672
- PMCID: PMC6963072
Low-grade fibromyxoid sarcoma: a clinicopathologic and molecular study of 10 genetically confirmed cases
Abstract
Low-grade fibromyxoid sarcoma (LGFMS) is a rare low-grade malignant fibroblastic tumor, harboring a characteristic FUS-CREB3L2 or FUS-CREB3L1 gene fusion. The authors presented 10 genetically confirmed cases in a Chinese population. To the best of our knowledge, the present series consists of the most genetically confirmed cases from a Chinese medical center in English literature. The clinical, histologic, immunohistochemical, and molecular features of all cases are reviewed. The age of the patients (7 females, 3 males) ranged from 4 to 58 years old (median, 26 y; mean, 27 y). Trunk (4/10, 40%) was the most common site. Microscopically, all the cases exhibited an admixture of myxoid nodules and fibrous zones. The tumor cells were deceptively bland and nuclear pleomorphism was observed in focal areas of one case. Immunohistochemically, neoplastic cells were focally reactive for EMA (1/9, 11.1%), and negative for S-100 protein, CD34, smooth muscle actin, and desmin (0/9). Of the 4 cases stained with MUC4, one showed focal expression and others were interpreted as indeterminate. Surgical excision was performed for all patients. Follow-up information was available for 8 cases, and none developed local recurrence or metastasis at last follow-up (mean 31 months). LGFMS is a distinctive low-grade malignant tumor. The diagnosis of this tumor might be very challenging and it is mistaken for many benign lesions. A combination of clinical studies, careful morphologic analysis, and a full panel of immunomarkers especially genetic studies is helpful in confirming the diagnosis. This tumor type is associated with favorable prognosis.
Keywords: FUS rearrangement; Low-grade fibromyxoid sarcoma; fluorescence in situ hybridization.
IJCEP Copyright © 2018.
Conflict of interest statement
None.
Figures




Similar articles
-
Low-grade fibromyxoid sarcoma: Clinical, morphologic and genetic features.Ann Diagn Pathol. 2017 Jun;28:60-67. doi: 10.1016/j.anndiagpath.2017.04.001. Epub 2017 Apr 5. Ann Diagn Pathol. 2017. PMID: 28648941
-
Low-grade fibromyxoid sarcoma of the breast: genetic characterization and immunohistochemical comparison to morphologic mimics.Hum Pathol. 2023 Sep;139:17-26. doi: 10.1016/j.humpath.2023.06.012. Epub 2023 Jun 29. Hum Pathol. 2023. PMID: 37392946
-
Low-Grade Fibromyxoid Sarcoma of the Head and Neck: A Clinicopathologic Series and Review of the Literature.Head Neck Pathol. 2016 Jun;10(2):161-6. doi: 10.1007/s12105-015-0647-8. Epub 2015 Aug 15. Head Neck Pathol. 2016. PMID: 26276044 Free PMC article. Review.
-
Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group.Am J Surg Pathol. 2007 Sep;31(9):1387-402. doi: 10.1097/PAS.0b013e3180321959. Am J Surg Pathol. 2007. PMID: 17721195
-
Low-grade Fibromyxoid Sarcoma of the Vulva and Vagina: Clinical, Pathologic, and Molecular Characterization of 7 Cases and Review of the Literature.Am J Surg Pathol. 2022 Sep 1;46(9):1196-1206. doi: 10.1097/PAS.0000000000001906. Epub 2022 Apr 13. Am J Surg Pathol. 2022. PMID: 35617488 Review.
Cited by
-
Knowledge, attitude, and practice of atrial fibrillation in high altitude areas.Front Public Health. 2024 Apr 10;12:1322366. doi: 10.3389/fpubh.2024.1322366. eCollection 2024. Front Public Health. 2024. PMID: 38660349 Free PMC article.
-
Case report: Primary pleural low-grade fibromyxoid sarcoma in a 4-year-old boy with molecular confirmation.Front Oncol. 2023 Dec 20;13:1269078. doi: 10.3389/fonc.2023.1269078. eCollection 2023. Front Oncol. 2023. PMID: 38179169 Free PMC article.
-
Low-Grade Fibromyxoid Sarcoma of the Distal Upper Extremity: A Systematic Review.Hand (N Y). 2024 Jul;19(5):701-708. doi: 10.1177/15589447221150523. Epub 2023 Jan 24. Hand (N Y). 2024. PMID: 36692100 Free PMC article.
-
The Expression of Mucin-4 (MUC4) in Sarcomas Apart From Sclerosing Epithelioid Fibrosarcoma and Low-Grade Fibromyxoid Sarcoma.Cureus. 2023 Nov 28;15(11):e49546. doi: 10.7759/cureus.49546. eCollection 2023 Nov. Cureus. 2023. PMID: 38156143 Free PMC article.
-
Low-Grade Myofibroblastic Sarcoma on Back with Repeated Localized Recurrence and Regional Metastasis.Ann Dermatol. 2023 Nov;35(Suppl 2):S219-S224. doi: 10.5021/ad.21.104. Ann Dermatol. 2023. PMID: 38061708 Free PMC article.
References
-
- Folpe AL, Hornick JL, Mertens F. Low-grade fibromyxoid sarcoma. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, editors. WHO classification of tumours of soft tissue and bone. 4th Edition. Lyon: Mertens F International Agency for Research on Cancer; 2013. pp. 95–96.
-
- Goldblum JR, Folpe AL, Weiss SW, editors. Enzinger and Weiss’s Soft Tissue Tumors. 6th Edition. Philadelphia: Saunders; 2013. Borderline and Malignant Fibroblastic/Myofbroblastic Tumors; pp. 324–332.
-
- Evans HL. Low-grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance. Am J Clin Pathol. 1987;88:615–619. - PubMed
-
- Evans HL. Low-grade fibromyxoid sarcoma. A report of 12 cases. Am J Surg Pathol. 1993;17:595–600. - PubMed
-
- Folpe AL, Lane KL, Paull G, Weiss SW. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes: a clinicopathologic study of 73 cases supporting their identity and assessing the impact of high-grade areas. Am J Surg Pathol. 2000;24:1353–1360. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials